ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0081

Impact of the COVID-19 Pandemic on Rheumatology Services in a Universal Healthcare Setting in Canada: A Population-based Study

Timothy Kwok1, Bindee Kuriya1, Lauren King1, Lihi Eder2, Carter Thorne3, Zhiyin Li4, therese stukel4, longdi fu4, alexander Kopp4 and Jessica Widdifield5, 1University of Toronto, Toronto, ON, Canada, 2Women’s College Research Institute, Department of Medicine, University of Toronto, Toronto, ON, Canada, 3Southlake Regional Health Centre, Newmarket, ON, Canada, 4ICES, Toronto, ON, Canada, 5Sunnybrook Research Institute, Toronto, ON, Canada

Meeting: ACR Convergence 2022

Keywords: Access to care, COVID-19, Health Services Research, population studies

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Saturday, November 12, 2022

Title: Health Services Research Poster I: Lupus, RA, Spondyloarthritis and More

Session Type: Poster Session A

Session Time: 1:00PM-3:00PM

Background/Purpose: We sought to describe changes in service delivery and access to rheumatologists in terms of changes in weekly total office visit volumes, telemedicine visits, and new consultations pre- and during-pandemic periods.

Methods: We conducted a population-based study in Ontario, Canada, where all residents are covered by a single-payer healthcare system. Patient visits with all rheumatologists in Ontario were ascertained using billing claims data (from January 2017 to October 4, 2021). Contacts with rheumatologists were separately defined by the type of patient encounter (including office visits, telemedicine visits, and new patient consultations). Changes in the total weekly volume of visits and monthly rates after COVID-19 public health measures were imposed were compared to expected baseline rates determined before pandemic onset (March 17, 2020, when a province-wide stay-at-home order was instituted in Ontario).

Results: In the 1 year prior to the pandemic, there were 289,202 unique patients (of which 99,641 were new consults) seen by 239 rheumatologists. In the 1 year following the pandemic onset, there were 276,686 patients (of which 88,777 were new consults) seen by 247 rheumatologists. There was an immediate 76% decrease in outpatient office visits at the onset of the pandemic and a rapid rise in telemedicine visits, Figure 1. By fall of 2021, 50% of patient encounters were still telemedicine visits. For new patient consultations, there was an immediate 50% decrease in total visits at the onset of the pandemic (cancelled/postponed), with 55% diverted to telemedicine visits in the first year of the pandemic vs. 38% by the fall of 2021, Figure 2. During the 12 months after pandemic restrictions were imposed, new rheumatology consultations decreased overall with monthly rates as low as 0.61 (95% CI 0.59, 0.62) of expected rates, with rate ratios less pronounced by fall 2021 (although rates of new consultations were already declining in the 3 years prior to the pandemic).

Conclusion: Rheumatology care delivery has shifted as a result of the pandemic, with telemedicine sharply increasing early in the pandemic and persisting over time. The pandemic also negatively impacted access to rheumatology services resulting in fewer new patient consultations. The longer-term impacts of these changes to rheumatology care delivery on quality of care, and delayed access to care warrants further research.

Supporting image 1

Figure 1

Supporting image 2

Figure 2


Disclosures: T. Kwok, None; B. Kuriya, None; L. King, None; L. Eder, AbbVie, Lilly, Novartis, UCB, Pfizer; C. Thorne, AbbVie/Abbott, Amgen, Celgene, CaREBiodam, Centocor, Janssen, Eli Lilly, Novartis, Pfizer, Sanofi, Medexus/Medac, Merck; Z. Li, None; t. stukel, None; l. fu, None; a. Kopp, None; J. Widdifield, None.

To cite this abstract in AMA style:

Kwok T, Kuriya B, King L, Eder L, Thorne C, Li Z, stukel t, fu l, Kopp a, Widdifield J. Impact of the COVID-19 Pandemic on Rheumatology Services in a Universal Healthcare Setting in Canada: A Population-based Study [abstract]. Arthritis Rheumatol. 2022; 74 (suppl 9). https://acrabstracts.org/abstract/impact-of-the-covid-19-pandemic-on-rheumatology-services-in-a-universal-healthcare-setting-in-canada-a-population-based-study/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2022

ACR Meeting Abstracts - https://acrabstracts.org/abstract/impact-of-the-covid-19-pandemic-on-rheumatology-services-in-a-universal-healthcare-setting-in-canada-a-population-based-study/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology